Articles by Jill Wechsler - Pharmaceutical Executive


Articles by Jill Wechsler

Risk and Restrictions

Nov 1, 2009

FDA and Congress weigh policies for improving drug safety via ads and written information.

Science and Safety

Oct 1, 2009

All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.

Going Global

Sep 1, 2009

Pharma steps up development of new vaccines and treatments to combat Third World diseases

Coverage Vs. Control

Aug 1, 2009

Pressure to expand healthcare puts drug pricing, marketing, and innovation on the negotiating table.

New NIH Leader Backs Personalized Medicine

Jul 22, 2009

Collins seeks to parlay genomic discoveries into new biomedical therapies. Comparative effectiveness research, he says, should identify subpopulation responses to treatment and support personalized medicine.

Safety and Security

Jul 1, 2009

As FDA looks to balance risks and benefits, more regulations are on the horizon.

A Bigger, Bolder Agency

Jun 1, 2009

FDA is seeking more resources to support compliance and oversight.

Wrangling Over Research Results

May 21, 2009

Marketers fear a Catch-22 if they have to write research summaries that FDA considers illegal promotion.

Compared to What?

May 1, 2009

Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine.


Click here